269 related articles for article (PubMed ID: 16289236)
1. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of connexin 32 gene on metastasis in renal cell carcinoma.
Sato H; Hagiwara H; Senba H; Fukumoto K; Nagashima Y; Yamasaki H; Ueno K; Yano T
Mol Carcinog; 2008 Jun; 47(6):403-9. PubMed ID: 18058801
[TBL] [Abstract][Full Text] [Related]
3. Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
Bhuvarahamurthy V; Schroeder J; Kristiansen G; Roigas J; Denkert C; Johannsen M; Lein M; Loening SA; Schnorr D; Jung K; Staack A
Oncol Rep; 2005 Sep; 14(3):777-82. PubMed ID: 16077991
[TBL] [Abstract][Full Text] [Related]
4. Expression of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and plasminogen activator inhibitors in patients with renal cell carcinoma: correlation with tumor associated macrophage and prognosis.
Ohba K; Miyata Y; Kanda S; Koga S; Hayashi T; Kanetake H
J Urol; 2005 Aug; 174(2):461-5. PubMed ID: 16006865
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Src activity enhances the tumor-suppressive effect of the connexin 32 gene in Caki-1 renal cancer cells.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Virgona N; Hagiwara K; Yamasaki H; Negishi E; Ueno K; Yano T
Oncol Rep; 2006 May; 15(5):1359-65. PubMed ID: 16596211
[TBL] [Abstract][Full Text] [Related]
6. A Src family inhibitor (PP1) potentiates tumor-suppressive effect of connexin 32 gene in renal cancer cells.
Fujimoto E; Sato H; Nagashima Y; Negishi E; Shirai S; Fukumoto K; Hagiwara H; Hagiwara K; Ueno K; Yano T
Life Sci; 2005 Apr; 76(23):2711-20. PubMed ID: 15792837
[TBL] [Abstract][Full Text] [Related]
7. Connexin32 as a tumor suppressor gene in a metastatic renal cell carcinoma cell line.
Fujimoto E; Sato H; Shirai S; Nagashima Y; Fukumoto K; Hagiwara H; Negishi E; Ueno K; Omori Y; Yamasaki H; Hagiwara K; Yano T
Oncogene; 2005 May; 24(22):3684-90. PubMed ID: 15782139
[TBL] [Abstract][Full Text] [Related]
8. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
[TBL] [Abstract][Full Text] [Related]
9. Connexin 32 potentiates vinblastine-induced cytotoxicity in renal cell carcinoma cells.
Sato H; Senba H; Virgona N; Fukumoto K; Ishida T; Hagiwara H; Negishi E; Ueno K; Yamasaki H; Yano T
Mol Carcinog; 2007 Mar; 46(3):215-24. PubMed ID: 17186540
[TBL] [Abstract][Full Text] [Related]
10. The urokinase-system in tumor tissue stroma of the breast and breast cancer cell invasion.
Hildenbrand R; Schaaf A
Int J Oncol; 2009 Jan; 34(1):15-23. PubMed ID: 19082473
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers.
Bobarykina AY; Minchenko DO; Opentanova IL; Moenner M; Caro J; Esumi H; Minchenko OH
Acta Biochim Pol; 2006; 53(4):789-99. PubMed ID: 17143338
[TBL] [Abstract][Full Text] [Related]
12. Renal synthesis of urokinase type-plasminogen activator, its receptor, and plasminogen activator inhibitor-1 in diabetic nephropathy in rats: modulation by angiotensin-converting-enzyme inhibitor.
Kenichi M; Masanobu M; Takehiko K; Shoko T; Akira F; Katsushige A; Takashi H; Yoshiyuki O; Shigeru K
J Lab Clin Med; 2004 Aug; 144(2):69-77. PubMed ID: 15322501
[TBL] [Abstract][Full Text] [Related]
13. The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha.
Samoylenko A; Dimova EY; Kozlova N; Drobot L; Kietzmann T
Thromb Haemost; 2010 May; 103(5):901-9. PubMed ID: 20216986
[TBL] [Abstract][Full Text] [Related]
14. Regulation of carcinoma cell invasion by protein C inhibitor whose expression is decreased in renal cell carcinoma.
Wakita T; Hayashi T; Nishioka J; Tamaru H; Akita N; Asanuma K; Kamada H; Gabazza EC; Ido M; Kawamura J; Suzuki K
Int J Cancer; 2004 Feb; 108(4):516-23. PubMed ID: 14696115
[TBL] [Abstract][Full Text] [Related]
15. Irradiation-induced regulation of plasminogen activator inhibitor type-1 and vascular endothelial growth factor in six human squamous cell carcinoma lines of the head and neck.
Artman T; Schilling D; Gnann J; Molls M; Multhoff G; Bayer C
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):574-82. PubMed ID: 20117293
[TBL] [Abstract][Full Text] [Related]
16. Expression and release of plasminogen activators, their inhibitors and receptor by human tumor cell lines.
Buø L; Bjørnland K; Karlsrud TS; Kvale D; Kjønniksen I; Fodstad O; Brandtzaeg P; Johansen HT; Aasen AO
Anticancer Res; 1994; 14(6B):2445-51. PubMed ID: 7872665
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
[TBL] [Abstract][Full Text] [Related]
18. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2.
Fujimoto E; Satoh H; Negishi E; Ueno K; Nagashima Y; Hagiwara K; Yamasaki H; Yano T
Mol Carcinog; 2004 Jul; 40(3):135-42. PubMed ID: 15224345
[TBL] [Abstract][Full Text] [Related]
19. Suppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signaling.
Xue A; Xue M; Jackson C; Smith RC
Int J Biochem Cell Biol; 2009; 41(8-9):1731-8. PubMed ID: 19433314
[TBL] [Abstract][Full Text] [Related]
20. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
